|
 |
|
|
 |
Company Overview
EnBIO has developed a novel, low temperature and low cost processing technology for the application of materials onto metal surfaces such as titanium, CoCr, NiTi, and stainless steel. The patent pending technology known as CoBlast™ has to-date been focused on treatments for hard tissue implants. EnBIO is working to exploit this technology with the recent launch of its OsteoZip™ surface for enhancing cell adhesion on orthopaedic and dental devices. A second application area involves the incorporation of drugs into the CoBlast deposited bioceramic coatings. This OsteoZap™ process is being developed to deposit bioceramic layers that exhibit anti-colonization functionality at the metal to bone interface.
The flexibility of the CoBlast process offers enormous potential. It can be used to deposit novel functionalities to the surface of any metallic implant. Compared with conventional processing technologies no high energy plasma sources are required, vacuum systems or chemical solution containment. EnBIO believes that this capability will lead to the development of new ideas and product concepts not heretofore considered. EnBIO offer a fully integrated single supplier solution for end-user surface modification requirements. This includes support and consultancy to tailor the CoBlast process to meet end user surface requirements, as well as the supply of equipment and media.
Mission Statement
At EnBIO, innovation is a cultural cornerstone, expressed not only in our technology breakthroughs but in the way we are organized and in our approach to fulfilling our mission as world leaders of surface modification technologies for metallic medical implants.
|
|
|
|
